Bioventus, Inc. (BVS)
12.89
+0.20
(+1.58%)
USD |
NASDAQ |
Oct 09, 11:50
Bioventus Profit Margin (Quarterly) : 23.63% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.63% |
| March 31, 2026 | 2.99% |
| December 31, 2025 | 10.97% |
| September 30, 2025 | 2.89% |
| June 30, 2025 | 6.28% |
| March 31, 2025 | -2.68% |
| December 31, 2024 | -0.39% |
| September 30, 2024 | -4.21% |
| June 30, 2024 | -22.63% |
| March 31, 2024 | -4.93% |
| December 31, 2023 | -5.65% |
| September 30, 2023 | -7.28% |
| June 30, 2023 | -3.45% |
| March 31, 2023 | -84.01% |
| December 31, 2022 | -28.14% |
| Date | Value |
|---|---|
| September 30, 2022 | -78.53% |
| June 30, 2022 | -5.51% |
| March 31, 2022 | -12.28% |
| December 31, 2021 | -1.45% |
| September 30, 2021 | -2.08% |
| June 30, 2021 | -9.82% |
| March 31, 2021 | 29.99% |
| December 31, 2020 | 1.60% |
| September 30, 2020 | 4.64% |
| June 30, 2020 | -12.46% |
| March 31, 2020 | 13.33% |
| December 31, 2019 | 3.85% |
| September 30, 2019 | 6.82% |
| March 31, 2016 | -9.25% |
| March 31, 2015 | -39.39% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Accuray, Inc. | -1.92% |
| Micron Solutions, Inc. | -- |
| IDEXX Laboratories, Inc. | 27.82% |
| Neogen Corp. | -5.34% |
| Orthofix Medical, Inc. | -7.49% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 26.76% |
| Return on Assets | 9.00% |
| Return on Invested Capital | 11.33% |
| Gross Profit Margin (Quarterly) | 68.29% |
| Operating Margin (Quarterly) | 12.23% |
| Return on Net Operating Assets | 9.85% |